Article Details

Imara lands $63M crossover round to trial sickle cell drug

Retrieved on: 2019-03-17 22:48:45

Tags for this article:

Click the tags to see associated articles and topics

Imara lands $63M crossover round to trial sickle cell drug. View article details on hiswai:

Excerpt

<div>By proposing a way to improve on the risk-benefit profile of hydroxyurea, Imara attracted investment from backers including <b>New Enterprise Associates</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up